新宙邦(300037.SZ):擬投資12億元建珠海新宙邦電子化學品項目
格隆匯11月30日丨新宙邦(300037.SZ)公佈,公司擬以全資子公司珠海新宙邦新材料有限公司(暫定名,以工商註冊登記為準,“珠海新宙邦”)為項目實施主體,在珠海經濟技術開發區新材料產業園投資建設珠海新宙邦電子化學品項目,項目總投資約12億元,一期建設週期28個月,預計2024年上半年逐步投產。
項目建設內容:年產10.5萬噸鋰電池材料、年產13萬噸半導體化學品、年產1.1萬噸電容化學品,電子化學品材料研究中試基地及配套的公用工程和輔助設施。
目前新宙邦已在華南、華東、華中、華北及東南地區建立了良好的產業佈局,建立了鋰離子電池電解液、電容化學品、半導體化學品、氟化學品等多個生產基地,但鑑於當前新能源、半導體產業的快速發展,目前公司華南基地已經不能滿足未來市場需求,因此在大灣區建設第二基地,實現雙基地供應保證,服務華南區域客户十分重要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.